These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36226551)

  • 1. Senotherapeutics and Their Molecular Mechanism for Improving Aging.
    Park J; Shin DW
    Biomol Ther (Seoul); 2022 Nov; 30(6):490-500. PubMed ID: 36226551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
    Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
    Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senotherapeutics in Cancer and HIV.
    Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Senescence in Human Skin Aging: Leveraging Senotherapeutics.
    Wyles SP; Carruthers JD; Dashti P; Yu G; Yap JQ; Gingery A; Tchkonia T; Kirkland J
    Gerontology; 2024; 70(1):7-14. PubMed ID: 37879300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
    Nehlin JO
    Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle aging, cellular senescence, and senotherapeutics: Current knowledge and future directions.
    Englund DA; Zhang X; Aversa Z; LeBrasseur NK
    Mech Ageing Dev; 2021 Dec; 200():111595. PubMed ID: 34742751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases.
    Matsubayashi S; Ito S; Araya J; Kuwano K
    Front Endocrinol (Lausanne); 2023; 14():1079626. PubMed ID: 37077349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Horizons in cellular senescence for clinicians.
    Witham MD; Granic A; Miwa S; Passos JF; Richardson GD; Sayer AA
    Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37466640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
    Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomolecular Evaluation of Piceatannol's Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
    Alessio N; Squillaro T; Lettiero I; Galano G; De Rosa R; Peluso G; Galderisi U; Di Bernardo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, Senescence, and Senolytics.
    Chaib S; Tchkonia T; Kirkland JL
    Handb Exp Pharmacol; 2022; 274():165-180. PubMed ID: 34697668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting senescent cells for a healthier longevity: the roadmap for an era of global aging.
    Sun Y; Li Q; Kirkland JL
    Life Med; 2022 Oct; 1(2):103-119. PubMed ID: 36699942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs and benefits of senotherapeutics for human health.
    Raffaele M; Vinciguerra M
    Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senotherapeutics: emerging strategy for healthy aging and age-related disease.
    Kim EC; Kim JR
    BMB Rep; 2019 Jan; 52(1):47-55. PubMed ID: 30526770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products.
    Mamun AA; Sufian MA; Uddin MS; Sumsuzzman DM; Jeandet P; Islam MS; Zhang HJ; Kong AN; Sarwar MS
    Eur J Pharmacol; 2022 Aug; 928():174991. PubMed ID: 35513016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies.
    Lucas V; Cavadas C; Aveleira CA
    Pharmacol Rev; 2023 Jul; 75(4):675-713. PubMed ID: 36732079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics.
    Han Y; Kim SY
    Exp Mol Med; 2023 Jan; 55(1):1-12. PubMed ID: 36599934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-targeted senotherapeutic interventions.
    Atayik MC; Çakatay U
    Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin aging from mechanisms to interventions: focusing on dermal aging.
    Shin SH; Lee YH; Rho NK; Park KY
    Front Physiol; 2023; 14():1195272. PubMed ID: 37234413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.